UCONN

HEALTH

Photo of Edward B. Perry, M.D.

Edward B. Perry, M.D.

Assistant Professor of Medicine
Medical Director, Neag Comprehensive Cancer Center Infusion Center
Academic Office Location:
Medicine
UConn Health
263 Farmington Avenue
Farmington, CT 06030-8040
Phone: 860-679-2100
Website(s):

Carole and Ray Neag Comprehensive Cancer Center

Hematologic Oncology

  • Looking for a Physician?

    This faculty member is also
    a practicing physician at UConn Health.

    Learn more >

Dr. Edward Perry is an assistant professor of medicine in the Division of Hematology/Oncology and the Carole and Ray Neag Comprehensive Cancer Center.

Education
DegreeInstitutionMajor
B.A.University of MississippiPhysics
M.D.University of AlabamaMedicine

Post-Graduate Training
TrainingInstitutionSpecialty
ResidencyVanderbilt University Medical CenterPsychiatry
FellowshipYale University School of MedicineResearch Fellow
ResidencyGeorge Washington University School of MedicineInternal Medicine
FellowshipUConn School of MedicineHematology/Oncology
Name & DescriptionCategoryRoleTypeScopeStart YearEnd Year
NCI PDQ Supportive and Palliative Care Editorial BoardEditorial BoardMemberExternalNational2016

Cancer-related fatigue, supportive care in cancer, psycho-oncology

Journal Articles

Book Chapters

  • The ketamine paradigm in humans: relevance to psychotic disorders
    Cho Hyun-Sang; Perry Edward; Gunduz-Bruce Handan; D’Souza Deepak C Glutamate in Neuropsychiatric Disorders 2008 Jan;1-31
  • Cannabinoid “model” psychosis, dopamine-cannabinoid interactions and implications for schizophrenia
    D’Souza Deepak C; Cho Hyun-Sang; Perry Edward; Krystal John H Marijuana and Madness: Psychiatry and Neurobiology 2004 Jun;142-165

Abstracts

  • Factors influencing fatigue in breast cancer patients undergoing breast irradiation.
    Edward Belk Perry; Sudhanshu Bharat Mulay; Jayesh Kamath; Robert J. Dowsett; Jacob Neuwirth; James Grady; Bruce Liang; Courtney Gold; Susan Tannenbaum Journal of Clinical Oncology 2016 May;33(5s):(suppl; abstr e20690)
Title or AbstractTypeSponsor/EventDate/YearLocation
Perry EB, Mulay SB, Kamath J, Dowsett RJ, Neuwirth J, Grady J, Gold C, Liang B, Tannenbaum S. Factors influencing fatigue in breast cancer patients undergoing breast irradiation.American Society of Clinical Oncology Breast Cancer Symposium2015San Francisco, California
Esterlis I, Mitsis EM, Batis JC, Bois F, Stiklus SM, Kloczynski TA, Perry EB, Tamagnan GD, Seibyl JP, Staley JK. Nicotine occupancy of beta2-nicotinic acetylcholine receptors after use of nicotine inhaler: relationship to craving.Joint Conference of Society for Research on Nicotine and Tobacco and Societ2009Dublin, Ireland
Esterlis I, Bois F, Cosgrove KP, Krantzler E, Stiklus SM, Perry E, Tamagnan GD, Seibyl JP, Krystal JH, Staley JK. [123I]Iomazenil SPECT imaging of nicotinic acetylcholine receptors in heavy drinking nonsmokers.2nd International Conference on Applications of Neuroimaging to Alcoholism2008New Haven, Connecticut
Cosgrove KP, Krantzler E, Perry E, Frohlich EB, Stiklus S, Tamagnan GD, Baldwin RM, Krystal JH, Staley JK. [123I]beta-CIT imaging of DAT and SERT availability in heavy alcohol drinkers during acute withdrawal.2nd International Conference on Applications of Neuroimaging to Alcoholism2008New Haven, Connecticut
Cosgrove KP, Staley JK, Wang F, Calhoun VD, Petrakis IL, Perry E, Frohlich EB, Ruff E, Blumberg H, Krystal JH. Decreased gray and white matter volume in alcohol-dependent subjects: a voxel-based morphometry study.2nd International Conference on Applications of Neuroimaging to Alcoholism2008New Haven, Connecticut
Esterlis I, Bois F, Batis JC, Perry E, McKee S, Tamagnan GD, Seibyl JP, O’Malley S, Staley JK. Imaging of nicotine occupancy of brain beta2-nicotinic receptors after smoking low nicotine and nicotine-free Quest cigarettes.Society for Research on Nicotine and Tobacco 14th Annual Meeting2008Portland, Oregon
D’Souza DC, Mathalon D, Perry E. Laboratory studies of ?-9 THC in humans: relevance to schizophrenia.1st Schizophrenia International Research Society Conference2008Venice, Italy
Cosgrove KP, Battis J, Esterlis I, Stiklus S, Kloczynksi T, Krishnan-Sarin S, O’Malley S, Bois F, Perry E, Tamagnan GD, Seibyl JP, Staley JK. Regulation of beta2-nicotinic acetylcholine receptors in living tobacco smokers during acute and prolonged abstinence: A [123I]-5-IA-85380 SPECT imaging study.Society for Research on Nicotine and Tobacco 14th Annual Meeting2008Portland, Oregon
Cosgrove KP, Bois F, Krantzler E, Epperson N, Perry E, Tamagnan G, Seibyl S, O’Malley S, Mazure C, Staley JK. Beta2-nicotinic acetylcholine receptor availability in men and women and throughout the menstrual cycle.Society for Research on Nicotine and Tobacco 13th Annual Meeting2007Austin, Texas
Esterlis I, Cosgrove KP, Bois F, Kloczynksi T, Stiklus SM, Perry E, Tamagnan GD, Seibyl JP, O’Malley S, Mason GF, Staley JK. [123I]Iomazenil SPECT imaging of GABAA-benzodiazepine receptor in smokers and nonsmokers.Society for Research on Nicotine and Tobacco 13th Annual Meeting2007Austin, Texas
D’Souza DC, Perry EB, Braley G, Cooper T, Krystal JH. Psychopharmacological evidence of cannabinoid and dopamine receptor interactions in humans: Implications for the link between cannabinoids and psychosis.International Congress on Schizophrenia Research 9th Annual Meeting2007Colorado Springs, Colorado
Cosgrove KP, Mitsis E, Bois F, Krantzler E, Epperson N, Perry E, Tamagnan G, Seibyl JP, O’Malley S, Maciejewski P, Mazure CM, van Dyck C, Staley JK. Nicotinic acetylcholine receptor availability in men and women nonsmokers.Society of Nuclear Medicine 54th Annual Meeting2007Washington, DC
Esterlis I, Cosgrove KP, Bois F, Kloczynksi T, Stiklus SM, Perry E, Mason G, Seibyl JP, O’Malley S, Staley JK. [123I]Iomazenil SPECT imaging of GABAA-benzodiazepine receptor in smokers and nonsmokers.Society of Nuclear Medicine 54th Annual Meeting2007Washington, DC
D’Souza DC, Gil RB, Madonick S, Perry EB, Forselius-Bielen K, Braley G, Donahue L, Tellioglu T, Zimolo Z, Gueorguieva R, Krystal JH. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia.30th Annual Meeting of the Research Society on Alcoholism2007Chicago, Illinois
Esterlis I, Cosgrove KP, Bois F, Kloczynksi T, Stiklus SM, Perry E, Tamagnan GD, Seibyl JP, Krishnan-Sarin S, O’Malley S, Mason GF, Staley JK. [123I]Iomazenil SPECT imaging of GABAA/benzodiazepine receptor in smokers and nonsmokers.College on Problems of Drug Dependence 69th Annual Meeting2007Quebec City, Canada
Perry EB, Krystal JH, Gueorguieva R, Belger A, Madonick SH, Abi-Dargham A, Cooper TB, MacDougall L, Abi-Saab W, D’Souza DC. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.International Congress on Schizophrenia Research 7th Annual Meeting2005Savannah, Georgia
Krystal JH, Perry EB, Abi-Saab W, D’Souza DC, Liu N, Gueorguieva R, MacDougall L, Hunsberger T, Belger A, Levine L, Breier A. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor (mGluR) agonist, LY354740, in healthy human subjects.International Congress on Schizophrenia Research 7th Annual Meeting2005Savannah, Georgia
D’Souza DC, Braley G, Perry E, Mathalon, Ford J, Krystal J. Delta-9-THC effects on information processing in humans.15th Annual Symposium on the Cannabinoids, International Cannabinoid Resear2005Clearwater, Florida
D’Souza DC, Braley G, Perry E, Abi-Saab D, Astur R. Delta-9-THC effects on virtual water maze performance in humans.15th Annual Symposium on the Cannabinoids, International Cannabinoid Resear2005Clearwater, Florida
Cosgrove KP, Frohlich EB, Terlecki MA, Perry E, Tamagnan GD, Seibyl JP, O’Malley S, Mazure CM, Staley JK. The influence of sex on the expression of beta2-nicotinic acetylcholine receptors using [123I]5-IA-85380 SPECT.College on Problems of Drug Dependence 67th Annual Scientific Meeting2005Orlando, Florida
D’Souza DC, Perry E, Mathalon D, Ford J, Zimolo Z, Gelernter J, Krystal JK. Emerging pharmacological evidence implicating cannabinoid receptor function in cognition and psychosis – implications for medication development.American College of Neuropsychopharmacology 44th Annual Meeting2005Waikoloa, Hawaii
Cho H, Mathalon D, Perry EB, Boutros N, Jacobsen L, Gueorguieva R, Blais RK, Donahue L, D'Souza DC, Krystal JH. Nicotine reduces deficits in cortical information processing and cognitive function produced by ketamine in humans.International Congress on Schizophrenia Research 7th Annual Meeting2005Savannah, Georgia
Abi-Saab D, Fiszdon J, Perry E, Usman M, Rajhans N, Bell M, Krystal J, D’Souza D. The relationship between neurocognition and functional measures in schizophrenia.International Congress on Schizophrenia Research 7th Annual Meeting2005Savannah, Georgia
Abi-Saab D, Perry E, Donahue L, Braley G, Krystal JH, D'Souza DC. The acute effects of delta (9)-tetrahydrocannabinol on memory and attention.Society of Biological Psychiatry 59th Annual Meeting2004New York, New York
Abi-Saab D, Perry E, Rajhans N, Bell M, Fiszdon J, Krystal J, D’Souza DC. Effects of cognitive training on neuropsychological and functional assessments.7th Annual Cognitive Remediation in Psychiatry Conference2004New York, New York
Zimolo Z, Krystal JH, Perry E, Wu T, Vangala S, Williams K, D’Souza DC. Proteomic analysis of glutamate modulation with riluzole in schizophrenia.Society for Neuroscience 34th Annual Meeting2004San Diego, California
Staley JK, Petrakis I, Tamagnan G, Krishnan-Sarin S, Perry E, Seibyl J, O’Malley S, Krystal JH. Correlation between severity of nicotine dependence and benzodiazepine receptor binding in alcoholics.Society for Research on Nicotine and Tobacco 9th Annual Meeting2003New Orleans, Louisiana
D'Souza DC, Perry E, Riccardi P, Abi-Saab W, Krystal J. Cannabinoids and psychosis: Pharmacological studies with IV ?-9-THC in humans.International Congress on Schizophrenia Research 5th Annual Meeting2003Colorado Springs, Colorado
Madonick S, D’Souza DC, Perry E, Krystal JH. Dose-related impact of naltrexone pretreatment upon the negative effects of ketamine in healthy human subjects.Research Society on Alcoholism 26th Annual Scientific Meeting2003Fort Lauderdale, Florida
Staley JK, Petrakis I, Gottschalk C, Seibyl JP, Verhoeff NP, Perry E, Van Dyck C, Baldwin RM, Krystal JH. Benzodiazepine receptor availability in recently abstinent alcohol dependent males: relationship to craving, withdrawal and smoking.American College of Neuropsychopharmacology 42nd Annual Meeting2003San Juan, Puerto Rico
Staley JK, Petrakis I, Tamagnan G, Krishnan-Sarin S, Perry E, Seibyl JP, O’Malley S, Krystal JH. [123I]Iomazenil SPECT imaging demonstrates correlation between severity of nicotine dependence and benzodiazepine receptor binding in alcohol dependent subjects.4th Annual European Conference of the Society for Research on Nicotine and2002Santander, Spain
D’Souza DC, Perry E, Riccardi P, Abi-Saab W, Krystal JH. Pharmacological evidence supporting the contribution of cannabinoid receptor function to psychosis.European Foundation for Psychiatry at the Maudsley2002London, England
Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N, McDougall L, Belger A, Levine L, Breier A. Modulation of ketamine-induced working memory deficits in healthy human subjects by the group II metabotropic agonist, LY354740.American College of Neuropsychopharmacology 41st Annual Meeting2002San Juan, Puerto Rico
Krystal JH, D’Souza DC, Belger A, Madonick S, Perry E. Dopaminergic modulation of NMDA antagonist effects in humans.American College of Neuropsychopharmacology 39th Annual Meeting2000San Juan, Puerto Rico
Perry E, Pieroni R. Hypobetalipoproteinemia: case report and literature review.Alabama Academy of Science 71st Annual Meeting1994Troy, Alabama